LEUVEN, Belgium, Nov. 5, 2013 (GLOBE NEWSWIRE) -- TiGenix NV (Euronext Brussels:TIG), the European leader in cell therapy, gives an update of its business activities and provides the financial highlights for the third quarter ending September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
